HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00

HCA Healthcare (NYSE:HCA) had its target price boosted by Mizuho from $505.00 to $520.00 in a research note released on Thursday morning, Marketbeat reports. The firm currently has an outperform rating on the stock.

Other equities analysts have also issued reports about the stock. Jefferies Financial Group boosted their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Barclays lifted their price target on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Finally, Stephens raised their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $479.00.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $472.69 on Thursday. The business has a 50 day simple moving average of $470.12 and a two-hundred day simple moving average of $417.03. The stock has a market capitalization of $107.87 billion, a P/E ratio of 18.27, a PEG ratio of 1.40 and a beta of 1.36. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the prior year, the company earned $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts anticipate that HCA Healthcare will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Institutional Trading of HCA Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Saudi Central Bank purchased a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare in the third quarter worth $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the 2nd quarter worth about $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.